Richard Crowley, EVP, Biopharmaceutical Operations at SAVIENT PHARMACEUTICALS INC (SVNT), sold 2,010 shares at $1.45 ($3K) on 2012-10-31, disclosed to the SEC on 2012-11-06.
Scheduled sale ($3k) by EVP, Biopharmaceutical Operations under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SVNT | SELL | 2013-02-06 | $51K | — | Filing → |
| SVNT | SELL | 2013-02-04 | $2K | — | Filing → |
| SVNT | SELL | 2012-08-03 | $2K | — | Filing → |